Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Bhvita Jani, medical imaging principal analyst, Signify Research, discusses growing trend of theragnostics in nuclear imaging and oncology at RSNA2023. #theragnostics #RSNA #RSNA23 #RSNA2023 #radiology #NucMed #Oncology

Theragnostics: A growing trend in molecular imaging

Bhvita Jani, medical imaging principal analyst at Signify Research, discusses the evolution of theragnostics and its applications in nuclear imaging and oncology.

Surveillance imaging of post-treatment cancer patients may cause more problems than it solves

After completing primary radiation therapy, patients in remission from cancers of the head and neck are better served by expectant management than routine imaging.

Roche, Ibex Medical Analytics and AWS partner for better cancer diagnostics

The three companies are partnering to bring AI tools to Roche’s digital pathology platform to streamline cancer diagnoses.

How to create a cardio-oncology program

Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.

SPECT/CT helps personalize treatment options for prostate cancer patients

Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care